Vivos Therapeutics Inc

NASDAQ:VVOS   9:35:00 AM EDT
2.52
+0.04 (+1.61%)
Earnings Announcements

Vivos Therapeutics Reports Q3 2021 Financial Results

Published: 11/15/2021 21:32 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update.
Q3 Revenue $4.5 Million.
Qtrly Loss per Share $0.26.
Revenue is expected to be $4.85 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $5.3 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.